Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Masters Speciality Pharma is a global pharmaceutical services company dedicated to improving patient access to essential medicines, particularly in emerging markets. Established in 1984, the company specializes in Managed Access Programs (MAPs), Named Patient supplies, and the commercial distribution of orphan drugs and oncology treatments. With a strong presence in Latin America and the Middle East, Masters facilitates the compliant delivery of unlicensed medicines to healthcare professionals for patients with unmet medical needs. The company provides end-to-end solutions including regulatory navigation, specialized logistics, and market access strategy for pharmaceutical manufacturers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Masters Speciality Pharma.